Rare allergic reactions, particularly in individuals with sensitivities to specific additives
Second, several states expanded Medicaid coverage to include GLP-1s specifically approved for obesity, such as Wegovy and Zepbound
3a) and scRNA-seq data (in Fig
Sermorelin therapy can range from a few months to a year or more
By leveraging the favorable material properties of PNP hydrogels, this work aims to provide a next-generation injectable therapeutic platform to transform T2D management and improve adherence across chronic treatment landscapes
The objective of the multisociety guidance is to offer unified guidance for clinicians for managing patients taking GLP-1 medications, regardless of indication, which currently includes DMT2, weight management, and heart failure